You just read:

Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients

News provided by

Sanofi

May 22, 2017, 17:47 ET